124 related articles for article (PubMed ID: 27109306)
1. Interaction of the LILRB1 inhibitory receptor with HLA class Ia dimers.
Baía D; Pou J; Jones D; Mandelboim O; Trowsdale J; Muntasell A; López-Botet M
Eur J Immunol; 2016 Jul; 46(7):1681-90. PubMed ID: 27109306
[TBL] [Abstract][Full Text] [Related]
2. A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1.
Apps R; Gardner L; Sharkey AM; Holmes N; Moffett A
Eur J Immunol; 2007 Jul; 37(7):1924-37. PubMed ID: 17549736
[TBL] [Abstract][Full Text] [Related]
3. Natural LILRB1 D1-D2 variants show frequency differences in populations and bind to HLA class I with various avidities.
Liu F; Cocker ATH; Pugh JL; Djaoud Z; Parham P; Guethlein LA
Immunogenetics; 2022 Dec; 74(6):513-525. PubMed ID: 35562487
[TBL] [Abstract][Full Text] [Related]
4. Extensive polymorphisms of LILRB1 (ILT2, LIR1) and their association with HLA-DRB1 shared epitope negative rheumatoid arthritis.
Kuroki K; Tsuchiya N; Shiroishi M; Rasubala L; Yamashita Y; Matsuta K; Fukazawa T; Kusaoi M; Murakami Y; Takiguchi M; Juji T; Hashimoto H; Kohda D; Maenaka K; Tokunaga K
Hum Mol Genet; 2005 Aug; 14(16):2469-80. PubMed ID: 16014635
[TBL] [Abstract][Full Text] [Related]
5. Soluble human leukocyte antigen-g5 activates extracellular signal-regulated protein kinase signaling and stimulates trophoblast invasion.
Guo Y; Lee CL; So KH; Gao J; Yeung WS; Yao Y; Lee KF
PLoS One; 2013; 8(10):e76023. PubMed ID: 24098421
[TBL] [Abstract][Full Text] [Related]
6. The Leukocyte Immunoglobulin-Like Receptor Family Member LILRB5 Binds to HLA-Class I Heavy Chains.
Zhang Z; Hatano H; Shaw J; Olde Nordkamp M; Jiang G; Li D; Kollnberger S
PLoS One; 2015; 10(6):e0129063. PubMed ID: 26098415
[TBL] [Abstract][Full Text] [Related]
7. Perspectives of targeting LILRB1 in innate and adaptive immune checkpoint therapy of cancer.
Zeller T; Münnich IA; Windisch R; Hilger P; Schewe DM; Humpe A; Kellner C
Front Immunol; 2023; 14():1240275. PubMed ID: 37781391
[TBL] [Abstract][Full Text] [Related]
8. Effect of cytomegalovirus infection and leukocyte immunoglobulin like receptor B1 polymorphisms on receptor expression in peripheral blood mononuclear cells.
Cadena-Mota S; Monsiváis-Urenda A; Salgado-Bustamante M; Monjarás-Ávila C; Bernal-Silva S; Aranda-Romo S; Noyola DE
Microbiol Immunol; 2018 Dec; 62(12):755-762. PubMed ID: 30461037
[TBL] [Abstract][Full Text] [Related]
9. Multimeric structures of HLA-G isoforms function through differential binding to LILRB receptors.
HoWangYin KY; Loustau M; Wu J; Alegre E; Daouya M; Caumartin J; Sousa S; Horuzsko A; Carosella ED; LeMaoult J
Cell Mol Life Sci; 2012 Dec; 69(23):4041-9. PubMed ID: 22802125
[TBL] [Abstract][Full Text] [Related]
10. Detection of weak ligand interactions of leukocyte Ig-like receptor B1 by fluorescence correlation spectroscopy.
Kuroki K; Kobayashi S; Shiroishi M; Kajikawa M; Okamoto N; Kohda D; Maenaka K
J Immunol Methods; 2007 Mar; 320(1-2):172-6. PubMed ID: 17217953
[TBL] [Abstract][Full Text] [Related]
11. Application of the immunoregulatory receptor LILRB1 as a crystallisation chaperone for human class I MHC complexes.
Mohammed F; Stones DH; Willcox BE
J Immunol Methods; 2019 Jan; 464():47-56. PubMed ID: 30365927
[TBL] [Abstract][Full Text] [Related]
12. LILRA3 binds both classical and non-classical HLA class I molecules but with reduced affinities compared to LILRB1/LILRB2: structural evidence.
Ryu M; Chen Y; Qi J; Liu J; Fan Z; Nam G; Shi Y; Cheng H; Gao GF
PLoS One; 2011 Apr; 6(4):e19245. PubMed ID: 21559424
[TBL] [Abstract][Full Text] [Related]
13. Entropically driven MHC class I recognition by human inhibitory receptor leukocyte Ig-like receptor B1 (LILRB1/ILT2/CD85j).
Shiroishi M; Kuroki K; Tsumoto K; Yokota A; Sasaki T; Amano K; Shimojima T; Shirakihara Y; Rasubala L; van der Merwe PA; Kumagai I; Kohda D; Maenaka K
J Mol Biol; 2006 Jan; 355(2):237-48. PubMed ID: 16305801
[TBL] [Abstract][Full Text] [Related]
14. Leukocyte immunoglobulin-like receptor B1 and B4 (LILRB1 and LILRB4): Highly sensitive and specific markers of acute myeloid leukemia with monocytic differentiation.
Churchill HRO; Fuda FS; Xu J; Deng M; Zhang CC; An Z; Zhang N; Chen P; Bergstrom C; Kansagra A; Collins R; John S; Koduru P; Chen W
Cytometry B Clin Cytom; 2021 Jul; 100(4):476-487. PubMed ID: 32918786
[TBL] [Abstract][Full Text] [Related]
15. Alternative mRNA splicing creates transcripts encoding soluble proteins from most LILR genes.
Jones DC; Roghanian A; Brown DP; Chang C; Allen RL; Trowsdale J; Young NT
Eur J Immunol; 2009 Nov; 39(11):3195-206. PubMed ID: 19658091
[TBL] [Abstract][Full Text] [Related]
16. Genetic diversity of the LILRB1 and LILRB2 coding regions in an admixed Brazilian population sample.
Oliveira MLG; Castelli EC; Veiga-Castelli LC; Pereira ALE; Marcorin L; Carratto TMT; Souza AS; Andrade HS; Simões AL; Donadi EA; Courtin D; Sabbagh A; Giuliatti S; Mendes-Junior CT
HLA; 2022 Oct; 100(4):325-348. PubMed ID: 35754199
[TBL] [Abstract][Full Text] [Related]
17. Structures of the four Ig-like domain LILRB2 and the four-domain LILRB1 and HLA-G1 complex.
Wang Q; Song H; Cheng H; Qi J; Nam G; Tan S; Wang J; Fang M; Shi Y; Tian Z; Cao X; An Z; Yan J; Gao GF
Cell Mol Immunol; 2020 Sep; 17(9):966-975. PubMed ID: 31273318
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms and expression of HLA-G and its receptors, KIR2DL4 and LILRB1, in non-small cell lung cancer.
Wiśniewski A; Kowal A; Wyrodek E; Nowak I; Majorczyk E; Wagner M; Pawlak-Adamska E; Jankowska R; Ślesak B; Frydecka I; Kuśnierczyk P
Tissue Antigens; 2015 Jun; 85(6):466-75. PubMed ID: 25855135
[TBL] [Abstract][Full Text] [Related]
19. Soluble HLA-G inhibits myeloid dendritic cell function in HIV-1 infection by interacting with leukocyte immunoglobulin-like receptor B2.
Huang J; Burke P; Yang Y; Seiss K; Beamon J; Cung T; Toth I; Pereyra F; Lichterfeld M; Yu XG
J Virol; 2010 Oct; 84(20):10784-91. PubMed ID: 20702625
[TBL] [Abstract][Full Text] [Related]
20. Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophages.
Zeller T; Lutz S; Münnich IA; Windisch R; Hilger P; Herold T; Tahiri N; Banck JC; Weigert O; Moosmann A; von Bergwelt-Baildon M; Flamann C; Bruns H; Wichmann C; Baumann N; Valerius T; Schewe DM; Peipp M; Rösner T; Humpe A; Kellner C
Front Immunol; 2022; 13():929339. PubMed ID: 36389667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
